Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 24
Filter
1.
FASEB J ; 36(12): e22639, 2022 12.
Article in English | MEDLINE | ID: mdl-36322029

ABSTRACT

Exposure of biological systems to acute or chronic insults triggers a host of molecular and physiological responses to either tolerate, adapt, or fully restore homeostasis; these responses constitute the hallmarks of resilience. Given the many facets, dimensions, and discipline-specific focus, gaining a shared understanding of "resilience" has been identified as a priority for supporting advances in cardiovascular health. This report is based on the working definition: "Resilience is the ability of living systems to successfully maintain or return to homeostasis in response to physical, molecular, individual, social, societal, or environmental stressors or challenges," developed after considering many factors contributing to cardiovascular resilience through deliberations of multidisciplinary experts convened by the National Heart, Lung, and Blood Institute during a workshop entitled: "Enhancing Resilience for Cardiovascular Health and Wellness." Some of the main emerging themes that support the possibility of enhancing resilience for cardiovascular health include optimal energy management and substrate diversity, a robust immune system that safeguards tissue homeostasis, and social and community support. The report also highlights existing research challenges, along with immediate and long-term opportunities for resilience research. Certain immediate opportunities identified are based on leveraging existing high-dimensional data from longitudinal clinical studies to identify vascular resilience measures, create a 'resilience index,' and adopt a life-course approach. Long-term opportunities include developing quantitative cell/organ/system/community models to identify resilience factors and mechanisms at these various levels, designing experimental and clinical interventions that specifically assess resilience, adopting global sharing of resilience-related data, and cross-domain training of next-generation researchers in this field.


Subject(s)
National Heart, Lung, and Blood Institute (U.S.) , Research Personnel , United States , Humans
2.
Vital Health Stat 1 ; (87): 1-26, 2021 04.
Article in English | MEDLINE | ID: mdl-34125665

ABSTRACT

Objectives Blood pressure (BP) is traditionally measured using a mercury sphygmomanometer. Given environmental concerns about mercury, clinical and survey settingsare moving to automated devices with an oscillometric protocol to obtain BP. This report compares BP measurement using the mercury and oscillometric protocols.


Subject(s)
Mercury , Sphygmomanometers , Blood Pressure , Blood Pressure Determination , Nutrition Surveys
4.
Int J Dermatol ; 55(4): e184-90, 2016 Apr.
Article in English | MEDLINE | ID: mdl-26566588

ABSTRACT

BACKGROUND: The pemphigus group is characterized by the presence of circulating immunoglobulins against desmosomes. IgG/IgA pemphigus is defined by the presence of IgG and IgA cell surface deposits upon direct immunofluorescence (DIF) and/or circulating IgG and IgA autoantibodies upon indirect immunofluorescence. Previous reports of patients with IgG/IgA pemphigus are sparse. Whether IgG/IgA pemphigus is best classified as a subtype of IgG (classic) pemphigus or IgA pemphigus, or as a distinct entity, has yet to be determined. OBJECTIVES: We compared the features of patients with IgG/IgA pemphigus to those of IgG pemphigus and IgA pemphigus. METHODS: Retrospective clinicopathologic study of patients with IgG, IgG/IgA, and IgA pemphigus evaluated at our clinic (1993-2013). RESULTS: We included 26, 13, and seven patients with IgG, IgG/IgA, and IgA pemphigus, respectively. Patients with IgG/IgA pemphigus did not differ significantly from patients with IgG pemphigus in terms of clinical and microscopic features, DIF findings, anti-desmoglein antibody values, and treatments required. However, patients with IgG/IgA pemphigus were significantly different from patients with IgA pemphigus regarding intertriginous distribution (P = 0.038) and pustular lesions (P < 0.001), acantholysis (P = 0.043), and presence of intercellular C3 deposits on DIF (P < 0.001). CONCLUSION: Comparative clinicopathologic data imply that IgG/IgA pemphigus may best be regarded as a variant of IgG pemphigus and distinct from IgA pemphigus.


Subject(s)
Immunoglobulin A/analysis , Immunoglobulin G/analysis , Pemphigus/metabolism , Pemphigus/pathology , Acantholysis/etiology , Adult , Aged , Autoantibodies/blood , Complement C3/analysis , Desmogleins/immunology , Female , Fluorescent Antibody Technique, Direct , Humans , Male , Middle Aged , Pemphigus/complications , Pemphigus/immunology , Retrospective Studies , Young Adult
7.
J Cutan Pathol ; 42(10): 693-8, 2015 Oct.
Article in English | MEDLINE | ID: mdl-26152335

ABSTRACT

BACKGROUND: The classic histopathologic features of lichen sclerosus et atrophicus (LS) include lymphoplasmacytic inflammation below a zone of dermal edema and sclerosis. The presence of eosinophils in LS has received little attention, but the finding of tissue eosinophils, particularly eosinophilic spongiosis in LS, has been suggested as a marker for the coexistence of autoimmune bullous disease or allergic contact dermatitis (or both). We sought to determine whether the histopathologic presence of dermal eosinophils or eosinophilic spongiosis (or both) in biopsies from patients with LS is associated with autoimmune bullous disease, autoimmune connective tissue disease or allergic contact dermatitis. METHODS: A retrospective review of the histopathology and medical records of 235 patients with LS who were evaluated from June 1992 to June 2012 was performed. RESULTS: Sixty-nine patients (29%) had eosinophils on histopathology. Among patients with associated diseases, a statistically significant association between the eosinophil cohort and the cohort without eosinophils was not detected. CONCLUSIONS: The importance of eosinophils is uncertain, but our data suggest that the finding of tissue eosinophils alone is not sufficient to prompt an extensive workup for additional diagnoses.


Subject(s)
Eosinophils/pathology , Lichen Sclerosus et Atrophicus/pathology , Adolescent , Adult , Aged , Aged, 80 and over , Biopsy , Child , Child, Preschool , Eosinophils/immunology , Female , Humans , Lichen Sclerosus et Atrophicus/immunology , Male , Middle Aged , Pemphigoid, Bullous/pathology , Retrospective Studies , Skin Diseases, Vesiculobullous/pathology
9.
COPD ; 12(4): 355-65, 2015 Aug.
Article in English | MEDLINE | ID: mdl-25244575

ABSTRACT

BACKGROUND: The study evaluated the change in the prevalence of airflow obstruction in the U.S. population 40-79 years of age from years 1988-1994 to 2007-2010. METHODS: Spirometry data from two representative samples of the U.S. population, the National Health and Nutrition Examination Surveys (NHANES) conducted in 1988-1994 and 2007-2010, were used. The American Thoracic Society/European Respiratory Society (ATS/ERS) criteria were used to define airflow obstruction. RESULTS: Based on ATS/ERS criteria, the overall age-adjusted prevalence of airflow obstruction among adults aged 40-79 years decreased from 16.6% to 14.5% (p < 0.05). Significant decreases were observed for the older age category 60-69 years (20.2% vs. 15.4%; p < 0.01), for males (19.0% vs. 15.4%; p < 0.01), and for Mexican American adults (12.7% vs. 8.4%; p < 0.001). The prevalence of moderate and more severe airflow obstruction decreased also (6.4% vs. 4.4%; p < 0.01). Based on ATS/ERS criteria, during 2007-2010, an estimated 18.3 million U.S. adults 40-79 years had airflow obstruction, 5.6 million had moderate or severe airflow obstruction and 1.4 million had severe airflow obstruction. CONCLUSIONS: The overall age-adjusted prevalence of airflow obstruction among U.S. adults aged 40-79 years decreased from 1988-1994 to 2007-2010, especially among older adults, Mexican Americans, and males.


Subject(s)
Pulmonary Disease, Chronic Obstructive/epidemiology , Adult , Aged , Cross-Sectional Studies , Female , Humans , Male , Middle Aged , Nutrition Surveys , Prevalence , Pulmonary Disease, Chronic Obstructive/diagnosis , Severity of Illness Index , Spirometry , United States/epidemiology
11.
Dermatol Surg ; 40(3): 275-80, 2014 Mar.
Article in English | MEDLINE | ID: mdl-24438475

ABSTRACT

BACKGROUND: Ultrasound imaging and ultrasound-guided fine-needle aspiration (FNA) are common procedures used to evaluate and sample cutaneous and subcutaneous tissue. Although ultrasound and FNA have been explored for individual neoplasms, lymph node involvement, and metastases, their use in day-to-day dermatology is not well defined. OBJECTIVE: To investigate the use and utility of ultrasound and FNA in the dermatologic surgery division of a large academic institution. METHODS: Retrospective case review of all ultrasound and FNA procedures ordered by a dermatologic surgeon over a 3-year period. RESULTS: Metastatic disease was suspected in 11 of 21 (52.4%) cases. Cytology confirmed the presence of metastatic disease in two of the 11 cases, and metastatic disease was identified in one additional case in which the diagnosis was not suspected at clinical presentation. Cytology revealed leukemia or lymphoma in three (14.3%) cases, two of which were new diagnoses. Sonographic imaging and cytology revealed a benign diagnosis in 16 (76.2%) cases, five of which were reactive lymph nodes. CONCLUSIONS: The results suggest that ultrasound and FNA are underused techniques that may play an important role in dermatology diagnostics and have the potential for expansion in day-to-day clinical practice.


Subject(s)
Biopsy, Fine-Needle , Dermatology/instrumentation , Skin Diseases/pathology , Ultrasonography , Diagnosis, Differential , Humans , Lymph Nodes/diagnostic imaging , Lymph Nodes/pathology , Retrospective Studies , Skin Diseases/diagnostic imaging
12.
Australas J Dermatol ; 55(4): e71-3, 2014 Nov.
Article in English | MEDLINE | ID: mdl-23651324

ABSTRACT

Reticulated acanthoma with sebaceous differentiation (RASD) represents a rare benign cutaneous epithelial neoplasm with sebaceous differentiation. There has been much speculation about the relationship between RASD and Muir-Torre syndrome (MTS). We report a 53 year-old man who presented with RASD in addition to a prior history of sebaceous adenomas. Immunohistochemically, the tumour cells in the RASD and sebaceous adenomas showed a significantly reduced MSH6 protein expression, whereas there was no loss of MLH1, MSH2 and PMS2. This benign neoplasm, which can be mistaken for various other cutaneous lesions with sebaceous differentiation, deserves wider recognition for its possible association with MTS.


Subject(s)
Acanthoma/pathology , Adenoma/pathology , Muir-Torre Syndrome/pathology , Neoplasms, Second Primary/pathology , Acanthoma/chemistry , Adaptor Proteins, Signal Transducing/analysis , Adenoma/chemistry , Adenosine Triphosphatases/analysis , Cell Differentiation , DNA Repair Enzymes/analysis , DNA-Binding Proteins/analysis , Humans , Male , Middle Aged , Mismatch Repair Endonuclease PMS2 , Muir-Torre Syndrome/metabolism , MutL Protein Homolog 1 , MutS Homolog 2 Protein/analysis , Neoplasms, Second Primary/chemistry , Nuclear Proteins/analysis , Sebaceous Glands/pathology
16.
Am J Dermatopathol ; 35(3): e53-6, 2013 May.
Article in English | MEDLINE | ID: mdl-23221471

ABSTRACT

Pyodermatitis-pyostomatitis vegetans (PPV) constitutes an inflammatory mucocutaneous dermatosis that is associated with inflammatory bowel disease. Clinically, PPV appears as pustules on mucosal surfaces and as vegetating exudative plaques on intertriginous surfaces. It is typically a clinical diagnosis supported by histological findings. Microscopic findings include epidermal hyperplasia, focal acantholysis, and a dense mixed inflammatory infiltrate with intraepithelial and subepithelial eosinophilic microabscesses. In the recent literature, immunofluorescence has been thought to be negative in PPV or, if positive, an aberrant finding. Herein, we report 2 cases of PPV associated with inflammatory bowel disease, which display intercellular IgA deposits. Although these cases may represent isolated epiphenomena, it is possible that the paucity of PPV cases with immunofluorescent studies hitherto has led to an oversight of an interesting association between intercellular IgA and PPV.


Subject(s)
Autoimmunity , Colitis, Ulcerative/immunology , Crohn Disease/immunology , Immunoglobulin A/analysis , Mouth Mucosa/immunology , Pemphigus/immunology , Skin/immunology , Autoimmunity/drug effects , Biopsy , Colitis, Ulcerative/complications , Colitis, Ulcerative/drug therapy , Crohn Disease/complications , Crohn Disease/drug therapy , Humans , Immunosuppressive Agents/therapeutic use , Male , Microscopy, Fluorescence , Middle Aged , Mouth Mucosa/drug effects , Mouth Mucosa/pathology , Pemphigus/classification , Pemphigus/drug therapy , Pemphigus/pathology , Skin/drug effects , Skin/pathology , Treatment Outcome , Young Adult
17.
Int J Dermatol ; 52(5): 629-30, 2013 May.
Article in English | MEDLINE | ID: mdl-22998391
18.
Mayo Clin Proc ; 87(10): 1004-14, 2012 Oct.
Article in English | MEDLINE | ID: mdl-22819486

ABSTRACT

Human herpesviruses (HHVs) have frequently been suspected as etiologic agents or cofactors in cutaneous disease. However, clearly established associations are rare. Investigations into an etiologic association between HHVs and cutaneous disease are complicated by the ubiquity and nearly universal prevalence of some herpesviruses. This article summarizes the associations between cutaneous disease and HHV-6, HHV-7, and HHV-8. In addition to a personal library of references, the PubMed database of biomedical literature was searched using the following Medical Subject Heading terms: HHV-6, HHV-7, and HHV-8, each in conjunction with cutaneous manifestations, virology, epidemiology, dermatopathology, and therapeutics, between 1998 and March 2011. Free-text searches with known or suspected disease associations were added for broader coverage. The results have been summarized to provide a practical review for the physician likely to encounter cutaneous diseases.


Subject(s)
Herpesvirus 6, Human/pathogenicity , Herpesvirus 7, Human/pathogenicity , Herpesvirus 8, Human/pathogenicity , Skin Diseases/pathology , Skin Diseases/virology , Humans , Sarcoma, Kaposi/pathology , Sarcoma, Kaposi/virology , Skin/pathology , Skin/virology , Skin Diseases, Viral/pathology , Skin Diseases, Viral/virology , Skin Neoplasms/pathology , Skin Neoplasms/virology
SELECTION OF CITATIONS
SEARCH DETAIL
...